Evolve Global Healthcare Enhanced Yield Fund (TSX:LIFE.B)
23.36
+0.13 (0.56%)
May 2, 2025, 9:30 AM EDT
-9.39% (1Y)
Assets | 34.96M |
Expense Ratio | 0.72% |
PE Ratio | n/a |
Dividend (ttm) | 2.50 |
Dividend Yield | 10.66% |
Ex-Dividend Date | Apr 30, 2025 |
Payout Frequency | Monthly |
Payout Ratio | n/a |
1-Year Return | n/a |
Volume | 112 |
Open | 23.36 |
Previous Close | 23.23 |
Day's Range | 23.36 - 23.36 |
52-Week Low | 22.25 |
52-Week High | 25.78 |
Beta | 1.00 |
Holdings | 94 |
Inception Date | Oct 25, 2017 |
About LIFE.B
Evolve Global Healthcare Enhanced Yield Fund is an exchange traded fund launched and managed by Evolve Funds Group Inc. The fund invests in public equity markets of global region. It invests directly and through derivatives in stocks of companies operating across health care sectors. The fund uses derivatives such as options to create its portfolio. It invests in growth and value stocks of large-cap companies. The fund seeks to track the performance of the Solactive Global Healthcare 20 Index Canadian Dollar Hedged. Evolve Global Healthcare Enhanced Yield Fund was formed on October 24, 2017 and is domiciled in Canada.
Asset Class Equity
Category Health Care
Stock Exchange Toronto Stock Exchange
Ticker Symbol LIFE.B
Provider Evolve
Index Tracked Solactive Global Healthcare 20 Index - CAD
Top 10 Holdings
131.71% of assetsName | Symbol | Weight |
---|---|---|
Canadian Dollar | n/a | 81.71% |
Gilead Sciences, Inc. | GILD | 6.01% |
AbbVie Inc. | ABBV | 5.64% |
Amgen Inc. | AMGN | 5.62% |
EssilorLuxottica Société anonyme | ESLOY | 5.56% |
Roche Holding AG | RHHBY | 5.51% |
Johnson & Johnson | JNJ | 5.49% |
Abbott Laboratories | ABT | 5.48% |
Novartis AG ADR | NVSN.MX | 5.41% |
Sanofi | SNY | 5.28% |
Dividend History
Ex-Dividend | Amount | Pay Date |
---|---|---|
Apr 30, 2025 | 0.230 CAD | May 7, 2025 |
Mar 31, 2025 | 0.230 CAD | Apr 7, 2025 |
Feb 28, 2025 | 0.230 CAD | Mar 7, 2025 |
Jan 31, 2025 | 0.230 CAD | Feb 7, 2025 |
Dec 31, 2024 | 0.230 CAD | Jan 8, 2025 |
Nov 29, 2024 | 0.230 CAD | Dec 6, 2024 |